Stocktoria
EXOZYMES INC. EXOZ
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-11-13
EXOZYMES INC. statistics & valuation
Market cap$72.8M
P / B21.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating margin | — | — | -2563.5% |
| Net margin | — | — | -2909.1% |
| FCF margin | — | — | -2097.3% |
| Return on assets | -153.4% | -45.0% | -57.3% |
| Return on equity | -269.6% | -56.2% | 530.4% |
| Current ratio | 2.51 | 8.12 | 0.50 |
Source: SEC EDGAR filings · CIK 0002010788 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.